Truist Financial Forecasts Strong Price Appreciation for Guardian Pharmacy Services (NYSE:GRDN) Stock

Guardian Pharmacy Services (NYSE:GRDN) had its target price lifted by equities researchers at Truist Financial from $22.00 to $24.00 in a report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective would suggest a potential upside of 14.67% from the stock’s current price.

Several other research firms also recently weighed in on GRDN. Raymond James started coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 target price for the company. Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target on the stock.

Guardian Pharmacy Services Stock Performance

Shares of NYSE:GRDN opened at $20.93 on Friday. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to analysts’ expectations of $303.21 million. On average, analysts expect that Guardian Pharmacy Services will post 0.79 earnings per share for the current year.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. bought 35,714 shares of the company’s stock in a transaction on Friday, September 27th. The shares were bought at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the acquisition, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several large investors have recently modified their holdings of the business. Allspring Global Investments Holdings LLC purchased a new position in Guardian Pharmacy Services during the third quarter valued at approximately $5,460,000. Seven Grand Managers LLC purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $2,515,000. Stephens Inc. AR bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter worth $189,000. Barclays PLC purchased a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth $311,000. Finally, Wellington Management Group LLP bought a new stake in Guardian Pharmacy Services during the third quarter valued at about $8,400,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.